<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35949299</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2516-5658</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>Vascular biology (Bristol, England)</Title><ISOAbbreviation>Vasc Biol</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2, platelets, and endothelium: coexistence in space and time, or a pernicious m&#xe9;nage &#xe0; trois?</ArticleTitle><Pagination><StartPage>R35</StartPage><EndPage>R43</EndPage><MedlinePgn>R35-R43</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1530/VB-22-0004</ELocationID><Abstract><AbstractText>As we enter year 3 of SARS-CoV-2 pandemic, long-term consequences of COVID-19 have become a major public health issue worldwide; however, the molecular and cellular underpinnings of 'long COVID' remain very poorly understood. A paradigm has recently emerged that thrombo-inflammatory consequences of SARS-CoV-2's impact on endothelial cells and platelets likely play a significant role in the development of chronic symptomatology associated with COVID-19. In this brief overview, we discuss the recent findings pertaining to the detection of SARS-CoV-2 virions in vascular cell subtypes, the contribution of the coagulation system to the development of 'long COVID', and the potential role of stem/progenitor cells in the viral and thrombotic dissemination in this disorder.</AbstractText><CopyrightInformation>&#xa9; The authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bogdanov</LastName><ForeName>Vladimir Y</ForeName><Initials>VY</Initials><Identifier Source="ORCID">0000-0003-4968-1129</Identifier><AffiliationInfo><Affiliation>Division of Hematology/Oncology, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khirmanov</LastName><ForeName>Vladimir N</ForeName><Initials>VN</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Nikiforov's All-Russian Center for Emergency and Radiation Medicine, Saint Petersburg, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Vasc Biol</MedlineTA><NlmUniqueID>101763329</NlmUniqueID><ISSNLinking>2516-5658</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">endothelium</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">platelets</Keyword><Keyword MajorTopicYN="N">thrombosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>11</Day><Hour>2</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35949299</ArticleId><ArticleId IdType="pmc">PMC9354055</ArticleId><ArticleId IdType="doi">10.1530/VB-22-0004</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Magro CM, Mulvey J, Kubiak J, Mikhail S, Suster D, Crowson AN, Laurence J, Nuovo G. Severe COVID-19: a multifaceted viral vasculopathy syndrome. Annals of Diagnostic Pathology 202150 151645. (10.1016/j.anndiagpath.2020.151645)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anndiagpath.2020.151645</ArticleId><ArticleId IdType="pmc">PMC7553104</ArticleId><ArticleId IdType="pubmed">33248385</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P, Luo R, Zhang M, Wang Y, Song T, Tao T, Li Z, Jin L, Zheng H, Chen W, et al. A cross-talk between epithelium and endothelium mediates human alveolar-capillary injury during SARS-CoV-2 infection. Cell Death and Disease 202011 1042. (10.1038/s41419-020-03252-9)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-020-03252-9</ArticleId><ArticleId IdType="pmc">PMC7721862</ArticleId><ArticleId IdType="pubmed">33293527</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh YJ, Hong H, Ohana M, Bompard F, Revel MP, Valle C, Gervaise A, Poissy J, Susen S, H&#xe9;kimian G, et al. Pulmonary embolism and deep vein thrombosis in COVID-19: a systematic review and meta-analysis. Radiology 2021298E70&#x2013;E80. (10.1148/radiol.2020203557)</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020203557</ArticleId><ArticleId IdType="pmc">PMC7745997</ArticleId><ArticleId IdType="pubmed">33320063</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicosia RF, Ligresti G, Caporarello N, Akilesh S, Ribatti D. COVID-19 vasculopathy: mounting evidence for an indirect mechanism of endothelial injury. American Journal of Pathology 20211911374&#x2013;1384. (10.1016/j.ajpath.2021.05.007)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2021.05.007</ArticleId><ArticleId IdType="pmc">PMC8141344</ArticleId><ArticleId IdType="pubmed">34033751</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaventura A, Vecchi&#xe9; A, Dagna L, Martinod K, Dixon DL, Van Tassell BW, Dentali F, Montecucco F, Massberg S, Levi M, et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nature Reviews: Immunology 202121319&#x2013;329. (10.1038/s41577-021-00536-9)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00536-9</ArticleId><ArticleId IdType="pmc">PMC8023349</ArticleId><ArticleId IdType="pubmed">33824483</ArticleId></ArticleIdList></Reference><Reference><Citation>Page EM, Ari&#xeb;ns RAS. Mechanisms of thrombosis and cardiovascular complications in COVID-19. Thrombosis Research 20212001&#x2013;8. (10.1016/j.thromres.2021.01.005)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2021.01.005</ArticleId><ArticleId IdType="pmc">PMC7813504</ArticleId><ArticleId IdType="pubmed">33493983</ArticleId></ArticleIdList></Reference><Reference><Citation>Perico L, Benigni A, Casiraghi F, Ng LFP, Renia L, Remuzzi G. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nature Reviews: Nephrology 20211746&#x2013;64. (10.1038/s41581-020-00357-4)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-020-00357-4</ArticleId><ArticleId IdType="pmc">PMC7570423</ArticleId><ArticleId IdType="pubmed">33077917</ArticleId></ArticleIdList></Reference><Reference><Citation>Stenmark KR, Frid MG, Gerasimovskaya E, Zhang H, McCarthy MK, Thurman JM, Morrison TE. Mechanisms of SARS-CoV-2-induced lung vascular disease: potential role of complement. Pulmonary Circulation 20211120458940211015799. (10.1177/20458940211015799)</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20458940211015799</ArticleId><ArticleId IdType="pmc">PMC8138299</ArticleId><ArticleId IdType="pubmed">34046161</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner JUG, Bojkova D, Shumliakivska M, Lux&#xe1;n G, Nicin L, Aslan GS, Milting H, Kandler JD, Dendorfer A, Heumueller AW, et al. Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants. Basic Research in Cardiology 2021116 42. (10.1007/s00395-021-00882-8)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-021-00882-8</ArticleId><ArticleId IdType="pmc">PMC8256413</ArticleId><ArticleId IdType="pubmed">34224022</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolci M, Signorini L, D'Alessandro S, Perego F, Parapini S, Sommariva M, Taramelli D, Ferrante P, Basilico N, Delbue S. In vitro SARS-CoV-2 infection of microvascular endothelial cells: effect on pro-inflammatory cytokine and chemokine release. International Journal of Molecular Sciences 202223 4063. (10.3390/ijms23074063)</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23074063</ArticleId><ArticleId IdType="pmc">PMC8999888</ArticleId><ArticleId IdType="pubmed">35409421</ArticleId></ArticleIdList></Reference><Reference><Citation>Manne BK, Denorme F, Middleton EA, Portier I, Rowley JW, Stubben C, Petrey AC, Tolley ND, Guo L, Cody M, et al. Platelet gene expression and function in patients with COVID-19. Blood 20201361317&#x2013;1329. (10.1182/blood.2020007214)</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007214</ArticleId><ArticleId IdType="pmc">PMC7483430</ArticleId><ArticleId IdType="pubmed">32573711</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaid Y, Puhm F, Allaeys I, Naya A, Oudghiri M, Khalki L, Limami Y, Zaid N, Sadki K, Ben El Haj R, et al. Platelets can associate with SARS-Cov-2 RNA and are hyperactivated in COVID-19. Circulation Research 20201271404&#x2013;1418. (10.1161/CIRCRESAHA.120.317703)</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317703</ArticleId><ArticleId IdType="pmc">PMC7641188</ArticleId><ArticleId IdType="pubmed">32938299</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakogiannis C, Sachse M, Stamatelopoulos K, Stellos K. Platelet-derived chemokines in inflammation and atherosclerosis. Cytokine 2019122 154157. (10.1016/j.cyto.2017.09.013)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2017.09.013</ArticleId><ArticleId IdType="pubmed">29198385</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Liu Y, Wang X, Yang L, Li H, Wang Y, Liu M, Zhao X, Xie Y, Yang Y, et al. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. Journal of Hematology and Oncology 202013 120. (10.1186/s13045-020-00954-7)</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-020-00954-7</ArticleId><ArticleId IdType="pmc">PMC7471641</ArticleId><ArticleId IdType="pubmed">32887634</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. New England Journal of Medicine 2020383120&#x2013;128. (10.1056/NEJMoa2015432)</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Escher F, Pietsch H, Aleshcheva G, Bock T, Baumeier C, Elsaesser A, Wenzel P, Hamm C, Westenfeld R, Schultheiss M, et al. Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies. ESC Heart Failure 202072440&#x2013;2447. (10.1002/ehf2.12805)</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.12805</ArticleId><ArticleId IdType="pmc">PMC7307078</ArticleId><ArticleId IdType="pubmed">32529795</ArticleId></ArticleIdList></Reference><Reference><Citation>Puelles VG, L&#xfc;tgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L, Chilla S, Heinemann A, Wanner N, Liu S, et al. Multiorgan and renal tropism of SARS-CoV-2. New England Journal of Medicine 2020383590&#x2013;592. (10.1056/NEJMc2011400)</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2011400</ArticleId><ArticleId IdType="pmc">PMC7240771</ArticleId><ArticleId IdType="pubmed">32402155</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl K, Br&#xe4;sen JH, Hoeper MM, David S. Direct evidence of SARS-CoV-2 in gut endothelium. Intensive Care Medicine 2020462081&#x2013;2082. (10.1007/s00134-020-06237-6)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06237-6</ArticleId><ArticleId IdType="pmc">PMC7483488</ArticleId><ArticleId IdType="pubmed">32915253</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet 20203951417&#x2013;1418. (10.1016/S0140-6736(2030937-5)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(2030937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirschenbaum D, Imbach LL, Rushing EJ, Frauenknecht KBM, Gascho D, Ineichen BV, Keller E, Kohler S, Lichtblau M, Reimann RR, et al. Intracerebral endotheliitis and microbleeds are neuropathological features of COVID-19. Neuropathology and Applied Neurobiology 202147454&#x2013;459. (10.1111/nan.12677)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12677</ArticleId><ArticleId IdType="pmc">PMC7753688</ArticleId><ArticleId IdType="pubmed">33249605</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko CJ, Harigopal M, Gehlhausen JR, Bosenberg M, McNiff JM, Damsky W. Discordant anti-SARS-CoV-2 spike protein and RNA staining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein. Journal of Cutaneous Pathology 20214847&#x2013;52. (10.1111/cup.13866)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cup.13866</ArticleId><ArticleId IdType="pubmed">32895985</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Han K, Blair R, Kenst K, Qin Z, Upcin B, W&#xf6;rsd&#xf6;rfer P, Midkiff CC, Mudd J, Belyaeva E, et al.SARS-CoV-2 infects endothelial cells in vivo and in vitro. Frontiers in Cellular and Infection Microbiology 202111 701278. (10.3389/fcimb.2021.701278)</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.701278</ArticleId><ArticleId IdType="pmc">PMC8292147</ArticleId><ArticleId IdType="pubmed">34307198</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccio U, Zinkernagel AS, Shambat SM, Zeng X, Cathomas G, Ruschitzka F, Schuepbach RA, Moch H, Varga Z. SARS-CoV-2 leads to a small vessel endotheliitis in the heart. EBiomedicine 202163 103182. (10.1016/j.ebiom.2020.103182)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.103182</ArticleId><ArticleId IdType="pmc">PMC7808909</ArticleId><ArticleId IdType="pubmed">33422990</ArticleId></ArticleIdList></Reference><Reference><Citation>Bermejo-Martin JF, Gonz&#xe1;lez-Rivera M, Almansa R, Micheloud D, Tedim AP, Dom&#xed;nguez-Gil M, Resino S, Mart&#xed;n-Fern&#xe1;ndez M, Ryan Murua P, P&#xe9;rez-Garc&#xed;a F, et al. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19. Critical Care 202024 691. (10.1186/s13054-020-03398-0)</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03398-0</ArticleId><ArticleId IdType="pmc">PMC7734467</ArticleId><ArticleId IdType="pubmed">33317616</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian Y, Lei T, Patel PS, Lee CH, Monaghan-Nichols P, Xin HB, Qiu J, Fu M. Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by simvastatin. Journal of Virology 202195e0139621. (10.1128/JVI.01396-21)</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01396-21</ArticleId><ArticleId IdType="pmc">PMC8577385</ArticleId><ArticleId IdType="pubmed">34549987</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossouw TM, Anderson R, Manga P, Feldman C. Emerging role of platelet-endothelium interactions in the pathogenesis of severe SARS-CoV-2 infection-associated myocardial injury. Frontiers in Immunology 202213 776861. (10.3389/fimmu.2022.776861)</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.776861</ArticleId><ArticleId IdType="pmc">PMC8854752</ArticleId><ArticleId IdType="pubmed">35185878</ArticleId></ArticleIdList></Reference><Reference><Citation>De Cristofaro R, Liuzzo G, Sacco M, Lancellotti S, Pedicino D, Andreotti F. Marked von Willebrand factor and factor VIII elevations in severe acute respiratory syndrome coronavirus-2-positive, but not severe acute respiratory syndrome coronavirus-2-negative, pneumonia: a case-control study. Blood Coagulation and Fibrinolysis 202132285&#x2013;289. (10.1097/MBC.0000000000000998)</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0000000000000998</ArticleId><ArticleId IdType="pubmed">33443926</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackman N, Grover SP, Antoniak S. Tissue factor expression, extracellular vesicles, and thrombosis after infection with the respiratory viruses influenza a virus and coronavirus. Journal of Thrombosis and Haemostasis 2021192652&#x2013;2658. (10.1111/jth.15509)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15509</ArticleId><ArticleId IdType="pmc">PMC9770926</ArticleId><ArticleId IdType="pubmed">34418279</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosell A, Havervall S, von Meijenfeldt F, Hisada Y, Aguilera K, Grover SP, Lisman T, Mackman N, Th&#xe5;lin C. Patients with COVID-19 have elevated levels of circulating extracellular vesicle tissue factor activity that is associated with severity and mortality-brief report. Arteriosclerosis, Thrombosis, and Vascular Biology 202141878&#x2013;882. (10.1161/ATVBAHA.120.315547)</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.315547</ArticleId><ArticleId IdType="pmc">PMC7837685</ArticleId><ArticleId IdType="pubmed">33267656</ArticleId></ArticleIdList></Reference><Reference><Citation>Guervilly C, Bonifay A, Burtey S, Sabatier F, Cauchois R, Abdili E, Arnaud L, Lano G, Pietri L, Robert T, et al. Dissemination of extreme levels of extracellular vesicles: tissue factor activity in patients with severe COVID-19. Blood Advances 20215628&#x2013;634. (10.1182/bloodadvances.2020003308)</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2020003308</ArticleId><ArticleId IdType="pmc">PMC7846479</ArticleId><ArticleId IdType="pubmed">33560376</ArticleId></ArticleIdList></Reference><Reference><Citation>Madeeva DV, Borges K, Shallow M, Juthani PV, Wang SY, Gupta A, Chun HJ, Lee AI, Pine AB. Proteomic profiles in patients with thrombosis due to COVID-19 are distinct from non-COVID-19 thrombosis. Blood 2021138 (Supplement 1) 777. (10.1182/blood-2021-153959)</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2021-153959</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, De Leacy RA, Shigematsu T, Ladner TR, Yaeger KA, et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. New England Journal of Medicine 2020382 e60. (10.1056/NEJMc2009787)</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2009787</ArticleId><ArticleId IdType="pmc">PMC7207073</ArticleId><ArticleId IdType="pubmed">32343504</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia X, Wang Y, Zheng J. COVID-19 and Alzheimer&#x2019;s disease: how one crisis worsens the other. Translational Neurodegeneration 202110 15. (10.1186/s40035-021-00237-2)</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-021-00237-2</ArticleId><ArticleId IdType="pmc">PMC8090526</ArticleId><ArticleId IdType="pubmed">33941272</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KG, Brokstad KA, Zhou F, Linchausen DW, Hansen BA, Lartey S, Onyango TB, Kuwelker K, S&#xe6;vik M, et al. Long COVID in a prospective cohort of home-isolated patients. Nature Medicine 2021271607&#x2013;1613. (10.1038/s41591-021-01433-3)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbasi J.Even mild COVID-19 may change the brain. JAMA 20223271321&#x2013;1322. (10.1001/jama.2022.4507)</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.4507</ArticleId><ArticleId IdType="pubmed">35319732</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y, Wu J, Chen T, Li J, Zhang G, Wu D, Zhou Y, Zheng N, Cai A, Ning Q, et al. Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations. Journal of Clinical Investigation 2021131 e147329. (10.1172/JCI147329)</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI147329</ArticleId><ArticleId IdType="pmc">PMC8262559</ArticleId><ArticleId IdType="pubmed">33630760</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller E, Brandi G, Winklhofer S, Imbach LL, Kirschenbaum D, Frontzek K, Steiger P, Dietler S, Haeberlin M, Willms J, et al. Large and small cerebral vessel involvement in severe COVID-19: detailed clinical workup of a case series. Stroke 2020513719&#x2013;3722. (10.1161/STROKEAHA.120.031224)</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.120.031224</ArticleId><ArticleId IdType="pmc">PMC7678671</ArticleId><ArticleId IdType="pubmed">33054673</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim R, Cheung G, Ting D, Wong E, Wong TY, Yeo I, Wong CW. Retinal microvascular signs in COVID-19. British Journal of Ophthalmology 2021. (10.1136/bjophthalmol-2020-318236)</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjophthalmol-2020-318236</ArticleId><ArticleId IdType="pubmed">33741583</ArticleId></ArticleIdList></Reference><Reference><Citation>Batra A, Clark JR, LaHaye K, Shlobin NA, Hoffman SC, Orban ZS, Colton K, Dematte JE, Sorond FA, Koralnik IJ, et al. Transcranial Doppler ultrasound evidence of active cerebral embolization in COVID-19. Journal of Stroke and Cerebrovascular Diseases 202130 105542. (10.1016/j.jstrokecerebrovasdis.2020.105542)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2020.105542</ArticleId><ArticleId IdType="pmc">PMC7837312</ArticleId><ArticleId IdType="pubmed">33341023</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento Conde J, Schutt WR, Gorbunova EE, Mackow ER. Recombinant ACE2 expression is required for SARS-CoV-2 to infect primary human endothelial cells and induce inflammatory and procoagulative responses. mBio 202011 e03185-20. (10.1128/mBio.03185-20)</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.03185-20</ArticleId><ArticleId IdType="pmc">PMC7751258</ArticleId><ArticleId IdType="pubmed">33310781</ArticleId></ArticleIdList></Reference><Reference><Citation>McCracken IR, Saginc G, He L, Huseynov A, Daniels A, Fletcher S, Peghaire C, Kalna V, Andaloussi-M&#xe4;e M, Muhl L, et al. Lack of evidence of angiotensin-converting enzyme 2 expression and replicative infection by SARS-CoV-2 in human endothelial cells. Circulation 2021143865&#x2013;868. (10.1161/CIRCULATIONAHA.120.052824)</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.052824</ArticleId><ArticleId IdType="pmc">PMC7899720</ArticleId><ArticleId IdType="pubmed">33405941</ArticleId></ArticleIdList></Reference><Reference><Citation>Schimmel L, Chew KY, Stocks CJ, Yordanov TE, Essebier P, Kulasinghe A, Monkman J, Dos Santos Miggiolaro AFR, Cooper C, de Noronha L, et al. Endothelial cells are not productively infected by SARS-CoV-2. Clinical and Translational Immunology 202110 e1350. (10.1002/cti2.1350)</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cti2.1350</ArticleId><ArticleId IdType="pmc">PMC8542944</ArticleId><ArticleId IdType="pubmed">34721846</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneko N, Satta S, Komuro Y, Muthukrishnan SD, Kakarla V, Guo L, An J, Elahi F, Kornblum HI, Liebeskind DS, et al. Flow-mediated susceptibility and molecular response of cerebral endothelia to SARS-CoV-2 infection. Stroke 202152260&#x2013;270. (10.1161/STROKEAHA.120.032764)</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.120.032764</ArticleId><ArticleId IdType="pmc">PMC7769899</ArticleId><ArticleId IdType="pubmed">33161843</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmetaj-Shala B, Vaja R, Atanur SS, George PM, Kirkby NS, Mitchell JA. Cardiorenal tissues express SARS-CoV-2 entry genes and basigin (BSG/CD147) increases with age in endothelial cells. JACC: Basic to Translational Science 202051111&#x2013;1123. (10.1016/j.jacbts.2020.09.010)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2020.09.010</ArticleId><ArticleId IdType="pmc">PMC7546186</ArticleId><ArticleId IdType="pubmed">33073064</ArticleId></ArticleIdList></Reference><Reference><Citation>Guney C, Akar F. Epithelial and endothelial expressions of ACE2: SARS-CoV-2 entry routes. Journal of Pharmacy and Pharmaceutical Sciences 20212484&#x2013;93. (10.18433/jpps31455)</Citation><ArticleIdList><ArticleId IdType="doi">10.18433/jpps31455</ArticleId><ArticleId IdType="pubmed">33626315</ArticleId></ArticleIdList></Reference><Reference><Citation>Maugeri N, De Lorenzo R, Clementi N, Antonia Diotti R, Criscuolo E, Godino C, Tresoldi C, Angels For Covid-BioB Study Group B, Bonini C, Clementi M, et al.Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19. Journal of Thrombosis and Haemostasis 202220434&#x2013;448. (10.1111/jth.15575)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15575</ArticleId><ArticleId IdType="pmc">PMC8646617</ArticleId><ArticleId IdType="pubmed">34710269</ArticleId></ArticleIdList></Reference><Reference><Citation>Bestle D, Heindl MR, Limburg H, Van Lam van T, Pilgram O, Moulton H, Stein DA, Hardes K, Eickmann M, Dolnik O, et al. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells. Life Science Alliance 20203 e202000786. (10.26508/lsa.202000786)</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.202000786</ArticleId><ArticleId IdType="pmc">PMC7383062</ArticleId><ArticleId IdType="pubmed">32703818</ArticleId></ArticleIdList></Reference><Reference><Citation>Wazny V, Siau A, Wu KX, Cheung C. Vascular underpinning of COVID-19. Open Biology 202010 200208. (10.1098/rsob.200208)</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.200208</ArticleId><ArticleId IdType="pmc">PMC7479931</ArticleId><ArticleId IdType="pubmed">32847471</ArticleId></ArticleIdList></Reference><Reference><Citation>Bugatti A, Filippini F, Bardelli M, Zani A, Chiodelli P, Messali S, Caruso A, Caccuri F. SARS-CoV-2 infects human ACE2-negative endothelial cells through an &#x3b1;v&#x3b2;3 integrin-mediated endocytosis even in the presence of vaccine-elicited neutralizing antibodies. Viruses 202214 705. (10.3390/v14040705)</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14040705</ArticleId><ArticleId IdType="pmc">PMC9032829</ArticleId><ArticleId IdType="pubmed">35458435</ArticleId></ArticleIdList></Reference><Reference><Citation>Ropa J, Cooper S, Capitano ML, Van&#x2019;t Hof W, Broxmeyer HE. Human hematopoietic stem, progenitor, and immune cells respond ex vivo to SARS-CoV-2 spike protein. Stem Cell Reviews and Reports 202117253&#x2013;265. (10.1007/s12015-020-10056-z)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-020-10056-z</ArticleId><ArticleId IdType="pmc">PMC7577648</ArticleId><ArticleId IdType="pubmed">33089452</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratajczak MZ, Bujko K, Ciechanowicz A, Sielatycka K, Cymer M, Marlicz W, Kucia M. SARS-CoV-2 entry receptor ACE2 is expressed on very small CD45- precursors of hematopoietic and endothelial cells and in response to virus spike protein activates the Nlrp3 inflammasome. Stem Cell Reviews and Reports 202117266&#x2013;277. (10.1007/s12015-020-10010-z)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-020-10010-z</ArticleId><ArticleId IdType="pmc">PMC7370872</ArticleId><ArticleId IdType="pubmed">32691370</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett TJ, Bilaloglu S, Cornwell M, Burgess HM, Virginio VW, Drenkova K, Ibrahim H, Yuriditsky E, Aphinyanaphongs Y, Lifshitz M, et al. Platelets contribute to disease severity in COVID-19. Journal of Thrombosis and Haemostasis 2021193139&#x2013;3153. (10.1111/jth.15534)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15534</ArticleId><ArticleId IdType="pmc">PMC8646651</ArticleId><ArticleId IdType="pubmed">34538015</ArticleId></ArticleIdList></Reference><Reference><Citation>Balzanelli MG, Distratis P, Dipalma G, Vimercati L, Inchingolo AD, Lazzaro R, Aityan SK, Maggiore ME, Mancini A, Laforgia R, et al. Sars-CoV-2 virus infection may interfere CD34+ hematopoietic stem cells and megakaryocyte-erythroid progenitors differentiation contributing to platelet defection towards insurgence of thrombocytopenia and thrombophilia. Microorganisms 20219 1632. (10.3390/microorganisms9081632)</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9081632</ArticleId><ArticleId IdType="pmc">PMC8400074</ArticleId><ArticleId IdType="pubmed">34442710</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucia M, Ratajczak J, Bujko K, Adamiak M, Ciechanowicz A, Chumak V, Brzezniakiewicz-Janus K, Ratajczak MZ. An evidence that SARS-Cov-2/COVID-19 spike protein (SP) damages hematopoietic stem/progenitor cells in the mechanism of pyroptosis in Nlrp3 inflammasome-dependent manner. Leukemia 2021353026&#x2013;3029. (10.1038/s41375-021-01332-z)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41375-021-01332-z</ArticleId><ArticleId IdType="pmc">PMC8219510</ArticleId><ArticleId IdType="pubmed">34163002</ArticleId></ArticleIdList></Reference><Reference><Citation>Nader D, Fletcher N, Curley GF, Kerrigan SW. SARS-CoV-2 uses major endothelial integrin &#x3b1;v&#x3b2;3 to cause vascular dysregulation in-vitro during COVID-19. PLoS ONE 202116 e0253347. (10.1371/journal.pone.0253347)</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0253347</ArticleId><ArticleId IdType="pmc">PMC8221465</ArticleId><ArticleId IdType="pubmed">34161337</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao Y, Saredy J, Xu K, Sun Y, Saaoud F, Drummer 4th C, Lu Y, Luo JJ, Lopez-Pastrana J, Choi ET, et al. Endothelial immunity trained by coronavirus infections, DAMP stimulations and regulated by anti-oxidant NRF2 may contribute to inflammations, myelopoiesis, COVID-19 cytokine storms and thromboembolism. Frontiers in Immunology 202112 653110. (10.3389/fimmu.2021.653110)</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.653110</ArticleId><ArticleId IdType="pmc">PMC8269631</ArticleId><ArticleId IdType="pubmed">34248940</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso P, Gidaro A, Gregato G, Raveane A, Cremonesi P, Quarna J, Caccia S, Gusso L, Rusconi S, Giacomelli A, et al. Circulating endothelial progenitors are increased in COVID-19 patients and correlate with SARS-CoV-2 RNA in severe cases. Journal of Thrombosis and Haemostasis 2020182744&#x2013;2750. (10.1111/jth.15044)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15044</ArticleId><ArticleId IdType="pmc">PMC7436444</ArticleId><ArticleId IdType="pubmed">32762140</ArticleId></ArticleIdList></Reference><Reference><Citation>Poyatos P, Luque N, Eizaguirre S, Sabater G, Sebasti&#xe1;n L, Francisco-Albesa &#xcd;, Peracaula M, Boixad&#xe9; M, Orriols R, Tura-Ceide O. Post-COVID-19 patients show an increased endothelial progenitor cell production. Translational Research 202224314&#x2013;20. (10.1016/j.trsl.2022.01.004)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2022.01.004</ArticleId><ArticleId IdType="pmc">PMC8785258</ArticleId><ArticleId IdType="pubmed">35085821</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishijima Y, Hader SN, Hanson AJ, Zhang DX, Sparapani R, Gutterman DD, Beyer AM. Prolonged endothelial-dysfunction in human arterioles following infection with SARS-CoV-2. Cardiovascular Research 202211818&#x2013;19. (10.1093/cvr/cvab339)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvab339</ArticleId><ArticleId IdType="pmc">PMC8689948</ArticleId><ArticleId IdType="pubmed">34755839</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffke M, Freitag H, Rudolf G, Seifert M, Doehner W, Scherbakov N, Hanitsch L, Wittke K, Bauer S, Konietschke F, et al. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS). Journal of Translational Medicine 202220 138. (10.1186/s12967-022-03346-2)</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03346-2</ArticleId><ArticleId IdType="pmc">PMC8938726</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature 2021594259&#x2013;264. (10.1038/s41586-021-03553-9)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nature Medicine 202228583&#x2013;590. (10.1038/s41591-022-01689-3)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M, Ciccarelli M, Cecconi M, Aghemo A, Morelli P, Gelardi F, Chiti A. Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study. European Journal of Nuclear Medicine and Molecular Imaging 2021481460&#x2013;1466. (10.1007/s00259-020-05084-3)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-05084-3</ArticleId><ArticleId IdType="pmc">PMC7595761</ArticleId><ArticleId IdType="pubmed">33123760</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Vlok M, Venter C, Bezuidenhout JA, Laubscher GJ, Steenkamp J, Kell DB. Persistent clotting protein pathology in long COVID/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovascular Diabetology 202120 172. (10.1186/s12933-021-01359-7)</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Fogarty H, Dyer A, Martin-Loeches I, Bannan C, Nadarajan P, Bergin C, O'Farrelly C, Conlon N, Bourke NM, et al. Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response. Journal of Thrombosis and Haemostasis 2021191064&#x2013;1070. (10.1111/jth.15267)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15267</ArticleId><ArticleId IdType="pmc">PMC8013297</ArticleId><ArticleId IdType="pubmed">33587810</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Yu Y, Trimpert J, Benthani F, Mairhofer M, Richter-Pechanska P, Wyler E, Belenki D, Kaltenbrunner S, Pammer M, et al. Virus-induced senescence is a driver and therapeutic target in COVID-19. Nature 2021599283&#x2013;289. (10.1038/s41586-021-03995-1)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03995-1</ArticleId><ArticleId IdType="pubmed">34517409</ArticleId></ArticleIdList></Reference><Reference><Citation>Paw&#x142;owski P.SARS-CoV-2 variant Omicron (B.1.1.529) is in a rising trend of mutations increasing the positive electric charge in crucial regions of the spike protein S. Acta Biochimica Polonica 202169263&#x2013;264. (10.18388/abp.2020_6072)</Citation><ArticleIdList><ArticleId IdType="doi">10.18388/abp.2020_6072</ArticleId><ArticleId IdType="pubmed">34905671</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Gao K, Wang R, Wei GW. Revealing the threat of emerging SARS-CoV-2 mutations to antibody therapies. Journal of Molecular Biology 2021433 167155. (10.1016/j.jmb.2021.167155)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2021.167155</ArticleId><ArticleId IdType="pmc">PMC8277955</ArticleId><ArticleId IdType="pubmed">34273397</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiecco G, Storti S, Degli Antoni M, Foc&#xe0; E, Castelli F, Quiros-Roldan E. Omicron genetic and clinical peculiarities that may overturn SARS-CoV-2 pandemic: a literature review. International Journal of Molecular Sciences 202223 1987. (10.3390/ijms23041987)</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23041987</ArticleId><ArticleId IdType="pmc">PMC8876558</ArticleId><ArticleId IdType="pubmed">35216104</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallejo S, Mendez-Echevarria A, Del Rosal T, Falces-Romero I, Mu&#xf1;oz-Caro JM, Buitrago S&#xe1;nchez NM, Arag&#xf3;n-Ramos P, Calvo C. Omicron and thrombosis in children: cause for concern? Pediatric Infectious Disease Journal 202241e252&#x2013;e254. (10.1097/INF.0000000000003501)</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003501</ArticleId><ArticleId IdType="pmc">PMC8997015</ArticleId><ArticleId IdType="pubmed">35213862</ArticleId></ArticleIdList></Reference><Reference><Citation>Halfmann PJ, Iida S, Iwatsuki-Horimoto K, Maemura T, Kiso M, Scheaffer SM, Darling TL, Joshi A, Loeber S, Singh G, et al. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters. NAture 2022603687&#x2013;692. (10.1038/s41586-022-04441-6).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04441-6</ArticleId><ArticleId IdType="pmc">PMC8942849</ArticleId><ArticleId IdType="pubmed">35062015</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernando K, Menon S, Jansen K, Naik P, Nucci G, Roberts J, Wu SS, Dolsten M. Achieving end-to-end success in the clinic: Pfizer&#x2019;s learnings on R&amp;D productivity. Drug Discovery Today 202127697&#x2013;704. (10.1016/j.drudis.2021.12.010)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2021.12.010</ArticleId><ArticleId IdType="pmc">PMC8719639</ArticleId><ArticleId IdType="pubmed">34922020</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty S, Gonzalez JC, Sievers BL, Mallajosyula V, Chakraborty S, Dubey M, Ashraf U, Cheng BY, Kathale N, Tran KQT, et al. Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity. Science Translational Medicine 202214 eabm7853. (10.1126/scitranslmed.abm7853)</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abm7853</ArticleId><ArticleId IdType="pmc">PMC8939764</ArticleId><ArticleId IdType="pubmed">35040666</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>